Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Jangmi | - |
dc.contributor.author | Kim, Hae-Young | - |
dc.contributor.author | Park, Seup | - |
dc.contributor.author | Sentissi, Ilham | - |
dc.contributor.author | Green, Nathan | - |
dc.contributor.author | Oh, Byung Kwon | - |
dc.contributor.author | Kim, Yujin | - |
dc.contributor.author | Oh, Kyung Hyun | - |
dc.contributor.author | Paek, Eunseong | - |
dc.contributor.author | Park, Young Joon | - |
dc.contributor.author | Oh, In-Hwan | - |
dc.contributor.author | Lee, Seung Heon | - |
dc.date.accessioned | 2022-06-23T03:40:17Z | - |
dc.date.available | 2022-06-23T03:40:17Z | - |
dc.date.created | 2022-06-22 | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/142335 | - |
dc.description.abstract | BackgroundDigital health technologies have been used to enhance adherence to TB medication, but the cost-effectiveness remains unclear. MethodsWe used the real data from the study conducted from April 2014 to December 2020 in Morocco using a smart pillbox with a web-based medication monitoring system, called Medication Event Monitoring Systems (MEMS). Cost-effectiveness was evaluated using a decision analysis model including Markov model for Multi-drug resistant (MDR) TB from the health system perspective. The primary outcome was the incremental cost-effectiveness ratio (ICER) per disability adjusted life-year (DALY) averted. Two-way sensitive analysis was done for the treatment success rate between MEMS and standard of care. ResultsThe average total per-patient health system costs for treating a new TB patient under MEMS versus standard of care were $398.70 and $155.70, respectively. The MEMS strategy would reduce the number of drug-susceptible TB cases by 0.17 and MDR-TB cases by 0.01 per patient over five years. The ICER of MEMS was $434/DALY averted relative to standard of care, and was most susceptible to the TB treatment success rate of both strategies followed by the managing cost of MEMS. ConclusionMEMS is considered cost-effective for managing infectious active TB in Morocco. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.subject | RESISTANT TUBERCULOSIS | - |
dc.subject | TREATMENT OUTCOMES | - |
dc.subject | RETREATMENT | - |
dc.subject | DEFAULT | - |
dc.subject | RELAPSE | - |
dc.title | Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Seung Heon | - |
dc.identifier.doi | 10.1371/journal.pone.0267292 | - |
dc.identifier.scopusid | 2-s2.0-85128627617 | - |
dc.identifier.wosid | 000791280100012 | - |
dc.identifier.bibliographicCitation | PLOS ONE, v.17, no.4 | - |
dc.relation.isPartOf | PLOS ONE | - |
dc.citation.title | PLOS ONE | - |
dc.citation.volume | 17 | - |
dc.citation.number | 4 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | RESISTANT TUBERCULOSIS | - |
dc.subject.keywordPlus | TREATMENT OUTCOMES | - |
dc.subject.keywordPlus | RETREATMENT | - |
dc.subject.keywordPlus | DEFAULT | - |
dc.subject.keywordPlus | RELAPSE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.